~~<i id='B1BD6DA948'><strike id='B1BD6DA948'><tt id='B1BD6DA948'><pre id='B1BD6DA948'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：comprehensive 2025-09-30 16:18:39 Page View：88

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Fed up with FDA, ALS advocates consider a take
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

comprehensive

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Color Health wants to make cancer screenings convenient

AColorHealthservicepromisestomakeiteasiertogetcancerscreenings.ColorHealthColorHealthwantstotakeaway

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Pfizer is about to make a big push in cancer. Will investors listen?

PfizerCEOAlbertBourlaGiannisPapanikos/APPfizerhasabigproblem.Thedruggianthopesthatnewdrugstotreatcan